 |
New Agents In Development For the Management of Obesity CME DisclosuresRelease Date: January 24, 2008; Valid for credit through January 24, 2009 |
| Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians | |
| Contents of This CME Activity | |
| The content of this CME activity, "New Agents in Development for the Management of Obesity," was developed by the faculty.
To participate in this activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.
Medications have gained acceptance for the management of obesity, although all currently available medications have some limitations. The current review examines the physiologic underpinnings of obesity as well as current and future trends in medications for treating obesity. New Agents In Development For the Management of Obesity
Royce P. Vincent, MD
Carel W. le Roux, MD, MRCP, MSc
Go to Test Questions |
| Legal Disclaimer | |
| The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity. Copyright © 2008 Medscape. |
|
|
Learning Objectives Upon completion of this activity, participants will be able to: - Describe neuroendocrine input into energy homeostasis
- Identify the efficacy of medications currently available to treat obesity
- List the limitations of medications currently available to treat obesity
- Describe possible future directions in the medical management of obesity
Authors and Disclosures |
 |
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Contact This Provider
|
|
